Dyne Therapeutics, Inc.
DYN
$18.44
$0.070.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 17.82% | 24.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.88% | 1.96% | |||
| Operating Income | -7.88% | -1.96% | |||
| Income Before Tax | -7.95% | -3.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.95% | -3.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.95% | -3.62% | |||
| EBIT | -7.88% | -1.96% | |||
| EBITDA | -7.89% | -1.97% | |||
| EPS Basic | 3.44% | 0.46% | |||
| Normalized Basic EPS | 3.46% | 0.44% | |||
| EPS Diluted | 3.44% | 0.46% | |||
| Normalized Diluted EPS | 3.46% | 0.44% | |||
| Average Basic Shares Outstanding | 11.80% | 4.10% | |||
| Average Diluted Shares Outstanding | 11.80% | 4.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||